Browse by author
Lookup NU author(s): Professor Penny Lovat, Professor Andrew Pearson, Dr Chris RedfernORCiD
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
The mechanisms of fenretinide-induced cell death of neuroblastoma cells are complex, involving signaling pathways mediated by free radicals or reactive oxygen species (ROS). The aim of this study was to identify mechanisms generating ROS and apoptosis of neuroblastoma cells in response to fenretinide. Fenretinide-induced ROS or apoptosis of SH-SY5Y or HTLA 230 neuroblastoma cells were not blocked by Nitro L-argenine methyl ester (L-NAME), an inhibitor of nitric oxide synthase. Flavoprotein-dependent superoxide-producing enzymes such as NADPH oxidase were also not involved in fenretinide-induced apoptosis or ROS generation. Similarly, ketoconazole, a cytochrome P450 inhibitor, and inhibitors of cyclooxygenase (COX) were also ineffective. In contrast, inhibition of phospholipase A2 or lipoxygenases (LOX) blocked the induction of ROS and apoptosis in response to fenretinide. Using specific inhibitors of LOX, blocking 12-LOX but not 5- or 15-LOX inhibited both fenretinide-induced ROS and apoptosis. The effects of eicosatriynoic acid, a specific 12-LOX inhibitor, were reversed by the addition of the 12-LOX products, 12 (S)-hydroperoxyeicosatetraenoic acid and 12 (S)-hydroxyeicosatetraenoic acid. The targeting of 12-LOX in neuroblastoma cells may thus be a novel pathway for the development of drugs inducing apoptosis of neuroblastoma with improved tumor specificity. © 2003 Wiley-Liss, Inc.
Author(s): Lovat, P.E., Ranalli, M., Corazzari, M., Raffaghello, L., Pearson, A.D.J., Ponzoni, M., Piacentini, M., Melino, G., Redfern, C.P.F.
Publication type: Article
Publication status: Published
Journal: Journal of Cellular Biochemistry
Year: 2003
Volume: 89
Issue: 4
Pages: 698-708
Print publication date: 01/07/2003
ISSN (print): 0730-2312
ISSN (electronic): 1097-4644
URL: http://dx.doi.org/10.1002/jcb.10551
DOI: 10.1002/jcb.10551
PubMed id: 12858336
Altmetrics provided by Altmetric
